Hepatitis with bridging fibrosis and reversible hepatic insufficiency in a woman with rheumatoid arthritis taking methotrexate.
A patient with seropositive rheumatoid arthritis developed ascites while taking weekly doses of methotrexate (MTX). Her serum transaminase and albumin levels were normal. A liver biopsy revealed chronic hepatitis with bridging fibrosis and piecemeal necrosis. Upon discontinuation of MTX, her ascites resolved, and her arthritis became more active. This is the third report of reversible hepatic decompensation associated with prolonged MTX therapy in patients with rheumatoid arthritis.
Kujala
G A
GA
Department of Medicine, West Virginia University School of Medicine, Morgantown 26506.
Shamma'a
J M
JM
Chang
W L
WL
Brick
J E
JE
D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy; D005260:Female; D006505:Hepatitis / Q000150:complications*; D006801:Humans; D008103:Liver Cirrhosis / Q000139:chemically induced*; D008107:Liver Diseases / Q000209:etiology*; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009336:Necrosis
D008727:Methotrexate